Pedro Cejas

Pedro Cejas

Company: Spark Therapeutics

Job title: Head of New Therapeutic Modalities


The Effect of DNA as an LNP Payload on Immunogenicity & Toxicity 12:15 pm

Investigating the impact of using DNA as a payload within LNP delivery systems on immunogenicity and toxicity Assessing the potential immune responses triggered by the presence of DNA components within LNPs Assessing the role of different LNP formulations and DNA payload designs in modulating the immune response and minimizing adverse reactionsRead more

day: Day Two AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.